Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study

BACKGROUND: The synthetic tetrahydrocannabinol analogue nabilone improved overall non‐motor symptom (NMS) burden in Parkinson's disease (PD) patients in comparison to placebo. OBJECTIVES: To characterize the effects of nabilone on different sleep outcomes in PD patients. METHODS: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peball, Marina, Seppi, Klaus, Krismer, Florian, Knaus, Hans‐Günther, Spielberger, Sabine, Heim, Beatrice, Ellmerer, Philipp, Werkmann, Mario, Poewe, Werner, Djamshidian, Atbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346252/
https://www.ncbi.nlm.nih.gov/pubmed/35937495
http://dx.doi.org/10.1002/mdc3.13471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346252/
https://www.ncbi.nlm.nih.gov/pubmed/35937495
http://dx.doi.org/10.1002/mdc3.13471

Ejemplares similares